Clinical Trial Update: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer [NA]

View source ↗

Summary

This clinical trial involves PET imaging with [18F]-FDG and [18F] Dihydro-Testosterone to study progressive prostate cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [18F] Dihydro-Testosterone (18F-dihydrotestosterone)
• [18F]-Fluoro-2-Deoxy-D-Glucose (2-deoxy-2-[18F]fluoro-D-glucose)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | NA | Status: RECRUITING